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The proper response to protein signals is necessary for a healthy central nervous system (CNS), 
and protein dysregulation is a feature of neurodegenerative diseases. Transactive response DNA-
binding protein-43 (TDP-43) is an intranuclear protein, but mislocalization is associated with 
amyotrophic lateral sclerosis (ALS). TDP-43 is released into the extracellular space where it is 
sensed by microglia, the CNS-resident immune cells. Our data and the literature suggest that 
microglia respond to TDP-43 dysregulation by increasing CNS inflammation. The goal of this 
study was to determine the impact of TDP-43 on microglial function and the extent to which 
microglia recovery. To study the inflammatory response, microglia were stimulated with TDP-43 
in a 2x2 factorial design with other inflammatory stimuli. Using iNOS and arginase colorimetric 
assays, we found that TDP-43 caused microglia to lose the ability to appropriately respond to 
inflammation. To study recovery, cultured microglia were stimulated with TDP-43 or a vehicle; 
then the media was changed to remove the stimuli and allow a recovery period. Markers of 
activation were measured using flow cytometry and metabolic assays. After recovery, microglia 
had a slight decrease in phagocytic capability as compared to TDP-43 stimulation without 
recovery. Microglia also demonstrated a metabolic shift toward glycolysis, consistent with a 
proinflammatory phenotype but returned to baseline levels of metabolic activity after recovery. 
These data demonstrate that dysregulated TDP-43 shifts the balance of signaling pathways 
toward an inflammatory phenotype, but microglia begin to recover after removal of the 
inflammatory stimuli. 
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Neuroinflammation describes the spectrum of Central Nervous System (CNS) immune 
responses in response to foreign stimuli and/or damage. Glial cells, including microglia and 
astrocytes are the primary cell types that regulate neuroinflammation through their ability to 
polarize to an M1 (proinflammatory) or M2 (anti-inflammatory) phenotype. Upon polarization, 
microglia secrete cytokines that allow crosstalk between the cells. This crosstalk causes changes 
in cellular functions such as phagocytosis and proliferation- leading to either a proinflammatory 
or anti-inflammatory phenotype. Tumor Necrosis Factor-α (TNF- α), Interferon-γ (IFN-γ), 
Interleukin-1 (IL-1) and Interleukin-6 (IL-6) are among the proinflammatory cytokines. They 
promote the M1 phenotype and are part of the innate immune response of the CNS. Interleukin-4 
(IL-4), Interleukin-13 (IL-13), and Transforming Growth Factor-β (TGF-β) are among the anti-
inflammatory cytokines, and they function as modulators of the M1 response, shifting the 
response toward M2. In a proinflammatory state, microglial functions are altered to increase 
uptake of cellular debris, proliferation, activation, and production of proinflammatory cytokines.  
When a proinflammatory response is excessively prolonged or intense, this can result in toxicity.  
In an anti-inflammatory state, effects of toxic inflammation caused by a polarizing stimulus will 
be regulated, returning homeostasis to the CNS. Prolonged neuroinflammation contributes to 
neurodegeneration which can lead to diseases such as Alzheimer’s disease (AD), Amyotrophic 
Lateral Sclerosis (ALS), and Frontotemporal Dementia (FTD)(McCauley and Baloh, 2019). 
Certain cellular molecules have a specific role within healthy cells but can become 
dysregulated upon exposure to a new environment. The molecules can be released through cell 
death or damage and induce an immune response when they are sensed by the novel environment 
(Vénéreau et al., 2015). For this reason, they are referred to as damage-associated molecular 
patterns (DAMPs). Many DAMPs are proteins, but they can also exist as non-protein molecules 
such as ATP, acids, and cytosolic DNA (Thundyil and Lim, 2015). Mislocalization from the 
intracellular space to the extracellular space can cause these molecules to either gain or lose 
functionality which leads to an immune response similar to the response to a pathogen. Protein 
DAMPs usually become dysregulated through either aggregation or misfolding upon 
mislocalization. In the CNS, mislocalization will allow the molecules to be sensed by immune 
cells such as microglia and astrocytes which leads to neuroinflammation and ultimately 
neurodegenerative disease. Transactive response DNA-binding protein-43 (TDP-43) is one such 
molecule (Pozzi et al., 2019). 
TDP-43 is usually an intranuclear protein that functions to regulate transcription and 
translation and subsequently stabilize the products (Cohen et al.; Jo et al., 2020; Pozzi et al., 
2019; Rosa Paolicelli et al., 2017). However, dysregulation of the protein is linked to certain 
neurodegenerative diseases such as ALS and FTD (Brettschneider et al., 2012; Correia et al., 
2015; Herman et al., 2012; Ishii et al., 2017; Svahn et al., 2018; Zhao et al., 2015). TDP-43 is 
mislocalized in the cerebrospinal fluid and blood plasma of patients with ALS, demonstrating its 
release into the extracellular space (Herman et al., 2012; Leal-Lasarte et al., 2017). In response to 
TDP-43, microglia will upregulate markers of activation such as Cluster of Differentiation-68 
(CD68) and ionized calcium binding adaptor molecule 1 (Iba1) (Brettschneider et al., 2012; 
Herman et al., 2012). Additionally, the production of proinflammatory cytokines IL-6 and TNF-
α increases after microglial stimulation with TDP-43 (Herman et al., 2012). These results 
demonstrate that TDP-43 is a proinflammatory and potentially toxic stimulus, but its effect on 
the CNS- specifically in the presence of other polarizing stimuli- is still not fully understood. 
Microglia are the primary immune cells of the central nervous system and respond to 
extracellular signals (Zhao et al., 2015). Microglia will engulf extracellular debris such as 
pathogens and weak neuronal synapses. Upon exposure to a polarizing stimulus, microglia will 
transition from a resting state to a highly activated state. In the resting state, microglia monitor 
the CNS for DAMPs, and they are characterized by minimal expression of major 
histocompatibility complex (MHC) class II and subsequently CD80, CD86, and CD40 
(Ponomarev et al., 2005). In an activated state, microglial morphology will change, and MHC 
class II and subsequent molecules will be upregulated (Ponomarev et al., 2005), leading to an 
increase in phagocytic activity, proliferation, and the upregulation of CD68, a marker of 
activation (Ponomarev et al., 2005). While this polarization is critical for essential immune 
responses, prolonged activation can lead to toxicity through the release of secretory products 
such as proteinases, cytokines, and reactive oxygen species (Banati et al., 1993). 
Mislocalization and aggregation of TDP-43 increases due to lipopolysaccharide (LPS) 
and TNFα-induced inflammation in primary microglia and astrocytes (Correia et al., 2015). 
Dysregulation of TDP-43 correlates with neuronal loss which could be due to the loss of nuclear 
function of TDP-43 and subsequent release into the extracellular space (Brettschneider et al., 
2012). Damage to microglial phagocytosis mechanisms contribute to the formation of 
dysregulated TDP-43. For example, disruption of lysosomal pathways impair the ability of 
microglia to clear degradation-resistant TDP-43 (Svahn et al., 2018). Microglia readily target 
cytosolic and extracellular TDP-43 aggregates for engulfment (Leal-Lasarte et al., 2017; Spiller 
et al., 2018). Upon phagocytosis, TDP-43 undergoes a series of modifications that triggers 
inflammasome-dependent neuroinflammation (Leal-Lasarte et al., 2017). This internalization of 
extracellular TDP-43 by microglia disrupts the MAPK/MAK/MRK overlapping kinase (MOK) 
signaling pathway (Leal-Lasarte et al., 2017). Additionally, TDP-43 stimulation upregulates 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2), TNF-α, and IL-1β 
(Zhao et al., 2015). This information suggests that microglia are activated by TDP-43 through 
the non-like receptor family pyrin domain containing 3 (NLRP3) and nuclear factor κ-light-
chain-enhancer of activated B cells (NF-κB) inflammasome which leads to a neurotoxic 
proinflammatory cascade (Leal-Lasarte et al., 2017; Zhao et al., 2015). In the absence of 
microglia, there is no neurotoxicity due to TDP-43 stimulation (Zhao et al., 2015), suggesting 
that TDP-43 causes a proinflammatory response of microglia that is toxic to motor neurons. 
TDP-43 is not the only extracellular stimulus linked to neuroinflammation. Other 
DAMPs such as beta-amyloid, tau, and α-synuclein have been linked to neurodegeneration 
resulting in diseases such as Alzheimer’s Disease and Parkinson’s disease. While all of these 
DAMPs are different, they contribute to neuroinflammation in similar ways. For example, beta-
amyloid induces activation of microglia resulting in an increase in production of 
proinflammatory cytokines and phagocytic activity (Koenigsknecht-Talboo and Landreth, 2005). 
Beta-amyloid also triggers neuroinflammation through the NF-κB inflammasome (Liu et al.). 
Additionally, beta-amyloid, tau, and α-synuclein are all known to form extracellular aggregates 
that contribute to the microglia’s ability to sense and engulf the proteins (Hensley et al., 1994; 
Marques and Outeiro, 2012; Yanamandra et al., 2013). These DAMPs contribute to 
neuroinflammation that can be beneficial, but often leads to microglial activation that promotes 
neurotoxicity and ultimately neurodegenerative disease (Drouin-Ouellet and Cicchetti, 2012). 
Dysregulated TDP-43 potentiates mechanisms that are implicated in neurological 
diseases such as ALS and FTD. The degree to which microglial polarization and responses to 
other proinflammatory stimuli as a result of TDP-43 is still under investigation. Additionally, 
there is evidence of central nervous system recovery after removal of TDP-43 but the impact on 
cell-autonomous microglia activation is still unclear (Pozzi et al., 2019). The goal of this study 
was to determine the how TDP-43 shapes microglial responses to neuroinflammation. We found 
that markers of proinflammatory activation such as CD68 expression, phagocytosis, and 
proinflammatory cytokine production were increased after TDP-43 stimulation, contributing to 
the characterization of TDP-43 as a proinflammatory stimulus. We also sought to ascertain the 
effect of TDP-43 on the polarization state of microglia in the presence of other proinflammatory 
cytokines. Finally, we wanted to determine the ability of microglia to recover from their 
proinflammatory phenotype after removal of TDP-43. We report that TDP-43 alters microglial 
responses to other neuroinflammatory signals, suggesting that in the presence of TDP-43, 
microglia not only shift toward a toxic phenotype, but they also lack the ability to respond to 
other inflammation. Additionally, we determined that microglia have the ability to return to 
baseline functioning after removal of TDP-43 from the extracellular space. In context of diseases 
such as ALS and FTD, these findings indicate that the microglial response to extracellular TDP-
43 promotes neuroinflammation linked to progression of neurodegeneration. 
 
Materials and Methods 
Cell culture: 
Immortalized mouse microglia (IMG cells) were used for all experiments. These microglia were 
immortalized from cells obtained from an 8-week old C57BL/6 mouse (McCarthy et al., 2016). 
IMG cells were obtained from Kerafast (Catalog #EF4001) cultured in high glucose Dulbecco’s 
modified Eagle medium (DMEM) (ATCC) supplemented with penicillin (100 units/ml), 
streptomycin (100 μg/ml), and 10% fetal bovine serum (FBS) (ATCC). Primary neurons were 
harvested from mouse brain cortices [and/or] hippocampi following kit instructions from 
BrainBits (KTEHP). Cells were plated at 100 cells/mL in poly-D-lysine coated plates in 
NbActiv1 media. 50% of media was changed every three days. All cells were incubated at 37°C, 
5% CO2, and 95% humidity.   
Experimental Design and reagents 
IMG cells were stimulated with transactive response DNA-binding protein-43 TDP-43 (100 
ng/mL) or vehicle buffer as a control (Zhao et al., 2015). Experiments compared TDP-43 treated 
cells to vehicle treated IMG cells or were a 2x2 factorial design with TDP-43 and polarizing 
stimuli as treatment factors. Recovery experiments compared TDP-43 treated to vehicle IMG 
cells. After the stimulation period, media was changed, and cells recovered for 24 hours. 
Recombinant TDP-43 (R&D Systems, AP-190-100) was stored at -80°C until use then 
resuspended in Hank’s Balanced Salt Solution (HBSS) to the working concentration immediately 
prior to use. Recombinant cytokines, interleukin-4 (10 ng/mL), interleukin-13 (5 ng/mL), and 
interferon-gamma (10 ng/mL), (Peprotech, #214-14, #210-13, #315-05, respectively) were 
dissolved in water then stored at -80°C until use.  
Proteomic analysis 
Cells were stimulated with TDP-43 or buffer for 36 hours then media was washed and scraped 
from the culture wells. Cell suspensions were pelleted by centrifugation, supernatant removed, 
then frozen on dry ice until analysis. Protein extractions was performed by chloroform/methanol 
extractions followed by a cysteine alkylation and tryptic digest. Samples were analyzed using an 
LTQ Orbitrap Mass Spectrometer (Udensi et al., 2014). Protein samples were normalized using a 
pooled sample created from each individual sample. Protein fragments were analyzed using 
Scaffold4 to identify proteins and generate relative fold-change values. Differential expression 
analysis and statistics were performed using Program R. Pathway analysis was performed using 
the Gene Ontology database. 
Neuronal phagocytosis 
Neuronal phagocytosis assays were adapted from previous protocols (Fricker et al., 2012). 
Primary neurons were cultured from brain tissue of C57BL/6 mice obtained from Brain Bits LLC 
(Brewer and Price, 1996; Brewer et al., 1993). Primary neurons were stimulated with Glutamate 
(10 uM) for 24 hours. IMG cells were stimulated in separate culture flasks. Neurons were labeled 
with TAMRA (50 μM). The media was removed from the neurons, and tetramethylrhodamine 
(TAMRA) in HBSS was added to the plate for 15 minutes. Then the neurons were washed, and 
media was replaced. IMG cells were counted and co-cultured with neurons at a concentration of 
50,000 cells per well. Co-culture was incubated 3 hours at 37°C, 5% CO2, and 95% humidity. To 
identify IMG cells, cultured cells were labelled with PE/Cy5 anti-mouse/human CD11b 
(Biolegend, Clone: M1/70, Catalog #101210). Cells were analyzed through flow cytometry. 
Neuronal phagocytosis was defined as presence of the TAMRA signal within CD11b+ cells. 
 
Bead-based phagocytosis 
Following IMG cell stimulation, media was removed, and cells were washed with 1 mL of 
HBSS. The bead-based phagocytosis protocol was modified from previously published reports 
(McCarthy et al., 2016). Fluorescent carboxylate modified latex beads (Sigma, Catalog #L4655) 
were added to IMG cells at a concentration of 2 µL/mL and incubated 1 hour at 37°C, 5% CO2, 
and 95% humidity. Cells were then washed, scraped, and resuspended in HBSS. Cells were 
analyzed by flow cytometry. Percent phagocytosis was defined as the percentage of cells the 
engulfed at least one fluorescent bead. 
Arginase Assay 
IMG cells were stimulated with TDP-43 and other polarizing stimuli for 36 hours. Then cells 
were lysed, and activity of Arginase enzymes was measured according to manufacturer’s 
instructions (Abcam, ab211083). Enzyme activity in cell lysates was measured by 
spectrophotometry. Briefly, cell lysates were exposed to a reaction mix containing Arginase 
Assay Buffer, Arginase Enzyme Mix, Arginase Developer, Arginase Converter Enzyme, and 
OxiRed Probe. Then the absorbance was immediately read at OD=570 µm in kinetic mode for 
10-30 minutes at 37°C. 
Inducible Nitric Oxide Synthase Assay 
IMG cells were stimulated with TDP-43 and other polarizing stimuli for 24 hours. Activity of 
iNOS enzymes was measured according to manufacturer’s instructions (Abcam, ab180877).  
Enzyme activity in cell lysates was measured by spectrophotometry. Briefly, Enhancer and 
Griess Reagents 1 and 2 were added, and samples sat for 10 minutes at room temperature. The 
absorbance was then measured on a microplate reader at OD=540 nm. 
Enzyme-linked Immunosorbent Assays (ELISA) 
IMG cells were stimulated for 36 hours. The cells were then lysed by adding .5% Tween 20 
detergent to previously prepared samples. The plate was wrapped with parafilm and stored at -
20°C for 24 hours. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were detected 
following manufacturer’s instructions (Biolegend, Catalog #431304, Catalog #4309904, 
respectively). Products were measured by spectrophotometry at 450 nm within 30 minutes. 
Functional Metabolic Measurements 
All metabolic data was collected using an Agilent Seahorse XFp Real-Time ATP Rate Assay Kit 
(Agilent, 103591-100). Glycolytic ATP production rate and mitochondrial ATP production rate 
were measured. Samples were prepared by stimulating IMG cells with TDP-43 and adding 
20,000 cells to each well. Sample cartridges were hydrated for 24-36 hours, and assay medium 
was prepared (1 mM Glutamate, 10 mM Glucose, and 1 mM Pyruvate). Oligomycin (75 µM) 
and Rotenone + Antimycin A (25 µM) were added to cartridge lid and placed in the instrument.  
After completion, the cartridge was wrapped in parafilm and stored at -20°C. 
Flow Cytometry 
All flow cytometry data was collected using an Accuri C6 flow cytometer (BD Biosciences). 
Cells could be fixed with a fixation and permeabilization solution (4.2% formaldehyde) (BD 
Biosciences, Catalog #554714) and labeled with APC anti-mouse CD-68 (Biolegend, Clone: FA-
11, Catalog #137007). Phagocytosis and CD-68 expression was analyzed through flow 
cytometry. Data was analyzed using FlowJo version 10.5. Cell gating and compensation 
strategies were determined using no stain and single color controls. 
Statistics 
All data were analyzed using GraphPad Prism version 8. Assumptions of normality and equality 
of variance were checked before statistical analysis was performed. One-way ANOVA or 
Student’s T-test was used for experiments with a single treatment factor while a two-way 
ANOVA was used for experiments with multiple treatment factors. All main-effect and 
interactions were investigated along with pre-planned pairwise comparisons. Alpha was 
designated as p=0.05, values below this threshold were considered significant.  
 
Results 
Figure 1. TDP-43 stimulation increases activation of IMG cells. 
 
1.A. IMG cells were stimulated with recombinant TDP-43 or a vehicle for 24 hours. Fluorescent 
beads were added to cell culture and phagocytized by IMG cells. Fluorescence signals were 
detected on Accuri C6 Flowcytometer. 1.B. Percent phagocytosis of stimulated IMG cells.  
Student’s t-test: n=8; ***=p<0.001; bars represent means ± 95% CI. 1.C. IMG cells were 
stimulated with recombinant TDP-43 or a vehicle for 24 hours. Cells were labelled with CD68 as 
a marker of activation.  Fluorescence signals were detected on Accuri C6 Flowcytometer. 1.D. 
Percent phagocytosis of CD68 positive and CD68 negative cells. Student’s t-test: n=8; 
***=p<0.001; bars represent means ± 95% CI. 1.E. IMG cells were stimulated with recombinant 
G H 
TDP-43 or a vehicle for 24 hours. Cells were labelled with CFSE, a DNA-binding fluorescent 
label.  Fluorescence signals were detected on Accuri C6 Flowcytometer. 1.F. Proliferation index 
stimulated IMG cells. Student’s t-test: n=8; bars represent means ± 95% CI. IMG cells were 
stimulated with recombinant TDP-43 or a vehicle for 24 hours. TNF-α (1.G) and IL-6 (1.H) 
production was measured via ELISA. Student’s t-test: n=8; ***=p<0.001; bars represent means 
± 95% CI.  
 
Figure 2. TDP-43 alters the polarization of IMG cells. 
 
IMG cells were stimulated with recombinant TDP-43 or a vehicle for 36 hours. IMG cells were 
also stimulated with the proinflammatory cytokine IFN-γ or the anti-inflammatory cytokines IL-
4 and IL-13. Nitrite production (2.A) and relative Arginase activity (2.B) were measured by a 
colorimetric assay and used as markers for pro-inflammatory or anti-inflammatory polarization, 













Figure 3. TDP-43 stimulation alters inflammation and metabolism-related proteins in microglia. 
 
Proteins associated with inflammation and metabolism were differentially regulated in TDP-43 
stimulated microglia compared to control cells. Graph represents the most significantly changed 
GO terms and the number of proteins associated with each GO term (group size). Differentially 
regulated proteins were associated with significant differences in a total of 159 GO terms. 
 
Figure 4. IMG cells recover after TDP-43 stimulation. 
 
IMG cells were stimulated with recombinant TDP-43 or a vehicle for 24 hours. Media was 
changed and cells recovered another 24 hours. Metabolic assays were conducted using an 
Agilent Seahorse XFp Real-Time ATP Rate Assay Kit. Mitochondrial ATP production (3.A) and 
glycolytic ATP production (3.B) were measured to determine altered metabolism of the 
stimulated IMG cells. One-way ANOVA: n=5; **=p<0.01; ***=p<0.001; bars represent ± 95% 
CI.  3.C. IMG cells were stimulated with recombinant TDP-43 or a vehicle for 24 hours. 
Fluorescent beads were added to cell culture and phagocytized by IMG cells. Fluorescence 
signals were detected on Accuri C6 Flowcytometer. One-way ANOVA: n=4; **=p<0.01; 
***=p<0.001; bars represent ± 95% CI. 3.D. IMG cells were stimulated with recombinant TDP-
A B C D 
43 or a vehicle for 24 hours. Cells were labelled with CD68 as a marker of activation. 
Fluorescence signals were detected on Accuri C6 Flowcytometer. One-way ANOVA: n=4; 
**=p<0.01; ***=p<0.001; bars represent ± 95% CI.   
 
TDP-43 drives pro-inflammatory activation 
Phagocytosis, Cluster of Differentiation 68 (CD68) expression, proliferation, and pro-
inflammatory cytokine production were measured as markers of microglial activation.  
Transactive response DNA-binding protein-43 (TDP-43)-stimulated immortilized microglial 
(IMG) cells were compared to vehicle treated IMG cells. Phagocytosis of fluorescent beads was 
increased in IMG cells treated with TDP-43 (Fig 1.A and 1.B). CD-68, a measure of lysosomal 
activation, expression was also increased in IMG cells treated with TDP-43 (Fig 1.C and 1.D).  
Increased phagocytosis and lysosome activity after stimulation with TDP-43 indicates that TDP-
43 polarizes microglia to a toxic phenotype. There was no change in proliferation between TDP-
43-treated and vehicle-treated IMG cells (Fig 1.E and 1.F). The production of pro-inflammatory 
cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) was increased (Fig 1.G and 
1.H). The production of the proinflammatory cytokines, TNF-α and IL-6 indicates that microglia 
are polarized in response to TDP-43.  
Inducible nitric oxide synthase (iNOS) and Arginase assays were used to determine if 
TDP-43 altered the polarization of IMG cells. Nitrite production was measured as an indicator of 
iNOS activity. The cytokine interferon-γ (IFN-γ) was used to polarize the IMG cells to a pro-
inflammatory state. Additional TDP-43 stimulation increased the pro-inflammatory activation 
(Fig 2.A). Relative arginase activity was measured as an indicator of anti-inflammatory 
activation. The cytokines IL-4 and IL-13 were used to polarize the IMG cells to an anti-
inflammatory state. Additional TDP-43 stimulation decreased the anti-inflammatory activation to 
control levels (Fig 2.B), indicating that TDP-43 inhibits the ability of microglia to respond 
appropriately to inflammation. 
 Proteomic analysis of TDP-43-treated and vehicle-treated microglia revealed that 159 
proteins were differentially expressed between the two groups. The most considerably altered 
proteins were primarily involved in inflammation and metabolism (Fig 3). This finding is 
consistent with data presented in figures 1 and 2.  
Microglia recover partially recover after TDP-43 removal 
Metabolic assays, phagocytosis, and CD-68 expression were used to determine if IMG 
cells could recover after TDP-43 stimulation. Mitochondrial ATP production showed no change 
across groups (Fig 4.A). Glycolytic ATP production increased after the stimulation period and 
returned to control levels following the recovery period (Fig 4.B). TDP-43 shifts the metabolic 
balance in microglial cells, but microglia recover after removal of the proinflammatory stimulus.  
Phagocytosis and CD-68 expression increased following TDP-43 stimulation as was previously 
shown. Phagocytosis, however, did not fully recover in the 24 hour recovery period (Fig 4.C). 
CD-68 expression also returned to control level following the recovery period (Fig 4.D). 
Microglia appear to be in the process of recovering, indicating that they may have the ability to 
recover normal functions after removal of TDP-43. 
TDP-43 promotes a proinflammatory phenotype in microglia (Fig 1) (Leal-Lasarte et al., 
2017; Zhao et al., 2015). Our data demonstrates that TDP-43 alters microglial polarization in the 
presence of inflammatory stimuli (Fig 2), suggesting that additional inflammation induced by 
TDP-43 impairs the ability of microglia to appropriately respond to extracellular cues. The 
ability of microglia to recover after the removal of extracellular TDP-43 suggests that the protein 
modifies the microglial response to polarizing stimuli (Fig 2). These data indicate that microglia 
have the ability to regain certain cellular functions, suggesting that the initial inflammatory 
effects of TDP-43 could be reversed with time (Fig 4). However, the mechanism(s) that underlie 
these findings is still unknown. This gap in knowledge provides a future direction to investigate 
the direct effect(s) of microglial recovery in TDP-43 proteinopathies. These conclusions 
contribute to an overall understanding of basic cellular mechanisms such as regulation of cellular 
plasticity and responses. Additionally, it provides insight into the potential damaging effects of 
protein dysregulation on the central nervous system. Most directly, this research contributes to 




The proper functioning of microglia is imperative for a healthy central nervous system. 
When microglia hyperpolarize, they lose their ability to respond appropriately to inflammation. 
Our research indicates that when mislocalized, transactive response DNA-binding protein-43 
(TDP-43) causes hyperpolarization of microglia which increases neuroinflammation and can 
potentially lead to neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and 
Frontotemporal Dementia (FTD). The goal of this study was to address the relationship between 
extracellular TDP-43 and microglia and subsequently evaluate the ability of microglia to recover 
after removal of TDP-43 from their extracellular environment. 
Classic markers of activation were present after stimulation with TDP-43. This finding is 
consistent with other research that suggests TDP-43 could be involved in potential toxic 
inflammatory responses (Brettschneider et al., 2012; Walker and Lue, 2015). Studies suggest that 
microglia proliferate in response to neurons with dysregulated TDP-43, however, stimulation 
with TDP-43 did not alter microglial proliferation (Spiller et al., 2018). While other researchers 
have explored the proinflammatory effect of TDP-43 on microglia, this is the first study that 
addresses the effect of TDP-43 stimulation on microglia previously stimulated with other 
polarizing stimuli. After TDP-43 stimulation, M1-activated microglial cells increased additively, 
whereas M2-activated microglia returned to baseline. This finding indicates that microglia lose 
their ability to polarize to an anti-inflammatory state in the presence of extracellular TDP-43, and 
subsequently lose the ability to respond to toxic inflammation. Additionally, TDP-43 stimulation 
increases microglial phagocytosis of neurons, indicating that TDP-43 causes microglia to 
polarize to a proinflammatory state that is toxic to surrounding brain tissues. Our data points to 
the toxicity of TDP-43, but additional research must be done to determine the full extent of this 
toxicity. 
For this study, immortalized microglia (IMG) were used because of their ease of care and 
ability to be grown in a time-efficient manner. There is evidence that basic functions and 
signaling mechanisms were conserved between primary microglia and IMG cells (McCarthy et 
al., 2016a). Microglial phagocytosis of primary neurons increased after stimulation with TDP-43, 
therefore, we show that TDP-43-treated microglia have the potential to be toxic to surrounding 
brain tissues. In future studies, we will test microglia with neurons acquired from patients with 
ALS. This is necessary to fully understand the effect of dysregulated TDP-43 in a legitimate 
disease context. In spite of these limitations, IMG cells were used because of how quickly and 
robustly they will grow in culture. This study informs the question of the effect of TDP-43 on 
microglia on a cellular level.  
Wild type TDP-43 was used in this study because it is found in cytoplasmic inclusions 
and extracellular aggregates in over 90% of ALS patients. In our proteomic analysis, we also 
found significant upregulation of intracellular TDP-43 in microglia after stimulation with 
extracellular TDP-43. Mutant TDP-43 is linked to familial ALS in approximately 4% of cases 
(Jo et al., 2020). There is evidence that mutant TDP-43 aggregates facilitate additional 
dysregulation and aggregation of wild-type TDP-43 which results in increased 
neurodegeneration (Mitchell et al., 2015). We show that TDP-43 stimulation altered metabolism 
in microglial cells. It has also been demonstrated that mutant TDP-43 and cytoplasmic TDP-43 
inclusions alter mitochondrial function in neurons (Wang et al., 2013). When directly comparing 
wild type TDP-43 to A315T mutant TDP-43, the wild type allele displayed greater toxicity than 
the mutant (Estes et al., 2011). However, the M337V mutant caused worsened disease 
phenotypes in comparison to wild type TDP-43 (Janssens et al., 2013).  
Proteomic analysis of TDP-43-stimulated microglia identified various pathways and 
genes that could be involved in TDP-43 pathology. Our study indicated that there was no change 
in microglial proliferation due to TDP-43 stimulation; however, proteomic analysis indicated that 
there were 28 altered proteins associated with GO:0042127 involved in proliferation. Among 
these were NOS2 and IFITM3 which encode inducible nitric oxide synthase (iNOS) and 
interferon induced transmembrane protein 3 (IFITM3). iNOS is associated with an M1 
polarization state, further characterizing the potentially toxic effect of the interaction between 
extracellular TDP-43 and microglia. IFITM3 interacts with interferons, and this is important for 
our study because we show that microglial interferon-γ production is increased after stimulation 
with TDP-43. iNOS was associated with 49 different GO terms, and IFITM3 was associated with 
12 different GO terms. One explanation as to why we found no change in proliferation is that 
highly proliferative cells, and therefore highly activated cells, could have died in the assay 
process. Additionally, there could be differences in how proliferation is measured. If cells are 
counted, there could be changes due to cell death. Alternatively, measuring proliferation based 
on DNA replication is likely a much accurate measurement. Proteomic analysis also indicated 
that various different metabolic pathways were altered by TDP-43. This is consistent with our 
glycolytic and mitochondrial ATP-production assay and fatty acid metabolism assay. 
After the extracellular TDP-43 was removed for a 24-hour recovery period, Cluster of 
Differentiation 68 (CD68) expression and ATP production returned to control levels and 
phagocytosis appeared to trend toward recovered function. This suggests that microglia do have 
the ability to recover after removal of TDP-43. Other studies have shown that protein-targeting 
antibodies can increase cognitive function. For example, when CD22, a B cell receptor that is a 
negative regulator of phagocytosis, is targeted by an antibody, microglial phagocytic activity in 
aged mice will recover to that of the control (Pluvinage et al. 2019). Additionally, when 
extracellular TDP-43 RNA recognition motif 1- the motif involved in protein aggregation- is 
targeted by single-chain antibodies, cognitive function is restored in mice (Pozzi et al., 2019). 
Based on this data as well as our own, we conclude that recovery is a conserved aspect of 
microglia and is likely independent of the stimulus. 
Overall, this study provides data which further characterizes the response of microglia to 
extracellular TDP-43. TDP-43 is a proinflammatory stimulus which could cause microglia to 
become toxic. This is shown by our novel polarization data which shows the effect of TDP-43 on 
microglia in the presence of other polarizing stimuli as well as our data which shows increased 
phagocytosis of primary neurons. This toxic microglial phenotype could lead to increased 
neuroinflammation which ultimately contributes to neurodegenerative disease such as ALS. 
Additionally, our data indicates that microglia have the ability to recover after the removal of 
TDP-43 from their extracellular space.  
This research sets the foundation for additional studies which explore the effect of removing 
extracellular TDP-43 in vivo. Other additional studies could focus on the mechanism through 
which TDP-43 causes neuroinflammation. Clarifying this mechanism could lead to a deeper 
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